698 related articles for article (PubMed ID: 27441452)
1. Long-term follow-up of psilocybin-facilitated smoking cessation.
Johnson MW; Garcia-Romeu A; Griffiths RR
Am J Drug Alcohol Abuse; 2017 Jan; 43(1):55-60. PubMed ID: 27441452
[TBL] [Abstract][Full Text] [Related]
2. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.
Garcia-Romeu A; Griffiths RR; Johnson MW
Curr Drug Abuse Rev; 2014; 7(3):157-64. PubMed ID: 25563443
[TBL] [Abstract][Full Text] [Related]
3. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.
Johnson MW; Garcia-Romeu A; Cosimano MP; Griffiths RR
J Psychopharmacol; 2014 Nov; 28(11):983-92. PubMed ID: 25213996
[TBL] [Abstract][Full Text] [Related]
4. Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.
Noorani T; Garcia-Romeu A; Swift TC; Griffiths RR; Johnson MW
J Psychopharmacol; 2018 Jul; 32(7):756-769. PubMed ID: 29938565
[TBL] [Abstract][Full Text] [Related]
5. An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.
Johnson MW; Garcia-Romeu A; Johnson PS; Griffiths RR
J Psychopharmacol; 2017 Jul; 31(7):841-850. PubMed ID: 28095732
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.
Agin-Liebes GI; Malone T; Yalch MM; Mennenga SE; Ponté KL; Guss J; Bossis AP; Grigsby J; Fischer S; Ross S
J Psychopharmacol; 2020 Feb; 34(2):155-166. PubMed ID: 31916890
[TBL] [Abstract][Full Text] [Related]
7. Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.
Johnson MW
Curr Top Behav Neurosci; 2022; 56():213-227. PubMed ID: 35704271
[TBL] [Abstract][Full Text] [Related]
8. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later.
Griffiths R; Richards W; Johnson M; McCann U; Jesse R
J Psychopharmacol; 2008 Aug; 22(6):621-32. PubMed ID: 18593735
[TBL] [Abstract][Full Text] [Related]
9. Cessation and reduction in alcohol consumption and misuse after psychedelic use.
Garcia-Romeu A; Davis AK; Erowid F; Erowid E; Griffiths RR; Johnson MW
J Psychopharmacol; 2019 Sep; 33(9):1088-1101. PubMed ID: 31084460
[TBL] [Abstract][Full Text] [Related]
10. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.
Carhart-Harris RL; Bolstridge M; Day CMJ; Rucker J; Watts R; Erritzoe DE; Kaelen M; Giribaldi B; Bloomfield M; Pilling S; Rickard JA; Forbes B; Feilding A; Taylor D; Curran HV; Nutt DJ
Psychopharmacology (Berl); 2018 Feb; 235(2):399-408. PubMed ID: 29119217
[TBL] [Abstract][Full Text] [Related]
11. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.
Bogenschutz MP; Forcehimes AA; Pommy JA; Wilcox CE; Barbosa PC; Strassman RJ
J Psychopharmacol; 2015 Mar; 29(3):289-99. PubMed ID: 25586396
[TBL] [Abstract][Full Text] [Related]
12. Potential Therapeutic Effects of Psilocybin.
Johnson MW; Griffiths RR
Neurotherapeutics; 2017 Jul; 14(3):734-740. PubMed ID: 28585222
[TBL] [Abstract][Full Text] [Related]
13. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.
Grob CS; Danforth AL; Chopra GS; Hagerty M; McKay CR; Halberstadt AL; Greer GR
Arch Gen Psychiatry; 2011 Jan; 68(1):71-8. PubMed ID: 20819978
[TBL] [Abstract][Full Text] [Related]
14. A Preliminary Investigation of a Relapse Prevention Mobile Application to Maintain Smoking Abstinence Among Individuals With Posttraumatic Stress Disorder.
Hicks TA; Thomas SP; Wilson SM; Calhoun PS; Kuhn ER; Beckham JC
J Dual Diagn; 2017; 13(1):15-20. PubMed ID: 27918881
[TBL] [Abstract][Full Text] [Related]
15. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Griffiths RR; Johnson MW; Carducci MA; Umbricht A; Richards WA; Richards BD; Cosimano MP; Klinedinst MA
J Psychopharmacol; 2016 Dec; 30(12):1181-1197. PubMed ID: 27909165
[TBL] [Abstract][Full Text] [Related]
16. Pilot Cases of Combined Cognitive Processing Therapy and Smoking Cessation for Smokers With Posttraumatic Stress Disorder.
Dedert EA; Resick PA; McFall ME; Dennis PA; Olsen M; Beckham JC
Behav Ther; 2016 Jan; 47(1):54-65. PubMed ID: 26763497
[TBL] [Abstract][Full Text] [Related]
17. Supervised, Vigorous Intensity Exercise Intervention for Depressed Female Smokers: A Pilot Study.
Patten CA; Bronars CA; Vickers Douglas KS; Ussher MH; Levine JA; Tye SJ; Hughes CA; Brockman TA; Decker PA; DeJesus RS; Williams MD; Olson TP; Clark MM; Dieterich AM
Nicotine Tob Res; 2017 Jan; 19(1):77-86. PubMed ID: 27613946
[TBL] [Abstract][Full Text] [Related]
18. Interventions for preventing weight gain after smoking cessation.
Parsons AC; Shraim M; Inglis J; Aveyard P; Hajek P
Cochrane Database Syst Rev; 2009 Jan; (1):CD006219. PubMed ID: 19160269
[TBL] [Abstract][Full Text] [Related]
19. Varying nicotine patch dose and type of smoking cessation counseling.
Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
[TBL] [Abstract][Full Text] [Related]
20. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.
Griffiths RR; Richards WA; McCann U; Jesse R
Psychopharmacology (Berl); 2006 Aug; 187(3):268-83; discussion 284-92. PubMed ID: 16826400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
